IP Library › Assignment 029801/0586
Patent Assignment
Reel/Frame 029801/0586

Change of Address

Recorded: 2013-02-12 Pages: 2
Assignor
ALEXION CAMBRIDGE CORPORATION
Executed: 2013-02-11
Assignee
ALEXION CAMBRIDGE CORPORATION
352 KNOTTER DRIVE, CHESHIRE, CONNECTICUT, 06410
Covered Properties (2)
Humaneered Anti-Factor B Antibody
Patent: 7,964,705 →
Application: 12/049,233 →
Publication: US 2008/0299114
Humaneered Anti-Factor B Antibody
Patent: 9,096,677 →
Application: 13/722,071 →
Publication: US 2013/0216529
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 9, 2008
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 021215/0595 →
Change of Name Dec 12, 2012
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029454/0515 →
Assignment of Assignor's Interest Feb 12, 2013
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 029799/0771 →
Change of Name Feb 12, 2013
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029799/0958 →
Merger Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →
Confirmatory License Jan 26, 2018
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045169/0549 →